Ubiquitin conjugating enzyme (E2) fusion proteins
AssigneeWisconsin Alumni Research Foundation
InventorsRichard David Vierstra, Mark Mattnew Gosink
Life of this patent
Estimating the term…
Abstract
A novel class of fusion proteins based on the ubiquitin-conjugating enzyme, or E2, is described. The fusion proteins include, in addition to the E2 activity, a protein binding ligand having a specific affinity for a target protein. It has been discovered that under cytosolic conditions, such E2 fusions will add a ubiquitin moiety to a target protein. Since ubiquitin addition triggers the endogenous cellular protein degradation pathway, such E2 fusion proteins can be used to selectively target proteins in a host for degradation. Thus, E2 fusion proteins genes can be introduced into transgenic organisms to defeat or inhibit natural activities or traits. The E2 fusion proteins can also be used by introduction into hosts for similar effects.
Claims13
A DNA sequence encoding an E2 fusion protein, the DNA sequence comprising:
- a promoter effective in the cells of a host to express a protein coding sequence located 3' to the promoter;
- and
- a DNA sequence encoding a fusion protein, the DNA fusion protein coding sequence located 3' to the promoter, the DNA sequence encoding the fusion protein including, 5' to 3':
- a DNA sequence encoding an E2 core region;
- a DNA sequence encoding a spacer of at least four amino acids;
- and
- a DNA sequence encoding a protein binding ligand having affinity for a target protein, the protein binding ligand not natively associated with any E2 protein, wherein
- the fusion protein encoded by the DNA sequence is capable of conjugating a ubiquitin moeity to proteins recognized by the protein binding ligand even in the ubiquitin protein ligase absence of an (E3).
A method of conjugating a ubiquitin moiety to a target protein comprising the steps of
- (a) constructing a DNA sequence for an E2 fusion protein including:
- a promoter effective in the cells of a host to express a protein coding sequence located 3' to the promoter;
- and
- a DNA sequence encoding an E2 fusion protein, the DNA sequence located 3' to the promoter, the DNA sequence encoding the fusion protein including, 5' to 3':
- a DNA sequence encoding an E2 core region;
- a DNA sequence encoding a spacer of at least four amino acids;
- and
- a DNA sequence encoding a protein binding ligand having affinity for the target protein, the protein binding ligand not natively associated with any E2 protein;
- (b) transforming the DNA sequence from step (a) into a host in which the promoter is capable of causing expression of the E2 fusion protein, so that the E2 fusion protein is produced in the host;
- and
- (c) exposing the E2 fusion protein to ubiquitin-linked E1, and a cellular source of energy so that the E2 fusion protein will accept the ubiquitin from the E1 and transfer the ubiquitin specifically to the target protein even in the absence of E3.
A DNA sequence encoding an E2 fusion protein, the DNA sequence comprising:
- a promoter effective in the cells of a host to express a protein coding sequence located 3' to the promoter;
- and
- a DNA sequence encoding a fusion protein located 3' to the promoter, the DNA sequence encoding fusion protein including, 5' to 3':
- a DNA sequence encoding an E2 core region;
- a DNA sequence encoding a spacer of at least four amino acids;
- and
- a DNA sequence encoding a protein binding ligand having affinity for a target protein, the protein binding ligand not natively associated with any E2 protein, the protein binding ligand being protein A wherein the fusion protein encoded by the fusion protein coding sequence is capable of conjugating a ubiquitin moeity to proteins to which protein A binds even in the absence of E3.
Dependencies are inferred from the claim text.